Reportstack

HanAll Biopharma Co., Ltd. - Product Pipeline Review - 2012 New Report

 
Repost This

Naperville, IL -- (SBWIRE) -- 09/24/2012 -- HanAll Biopharma Co., Ltd. - Product Pipeline Review - 2012 provides data on the HanAll Biopharma Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- HanAll Biopharma Co., Ltd. - Brief HanAll Biopharma Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of HanAll Biopharma Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of HanAll Biopharma Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the HanAll Biopharma Co., Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate HanAll Biopharma Co., Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of HanAll Biopharma Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the HanAll Biopharma Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with HanAll Biopharma Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of HanAll Biopharma Co., Ltd. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of HanAll Biopharma Co., Ltd.; HanAll Biopharma Co., Ltd. - Key Therapeutics; HanAll Biopharma Co., Ltd. - Pipeline Overview and Promising Molecules; HanAll Biopharma Co., Ltd. - News; HanAll Biopharma Co., Ltd. - Latest Updates; HanAll Biopharma Co., Ltd. - Pipeline; HanAll Biopharma Co., Ltd. - Discontinued/Dormant Projects

To view table of contents for this market report please visit:
http://www.reportstack.com/product/89931/hanall-biopharma-co-ltd-product-pipeline-review-2012.html